Studies in murine models of induced chronic migraine have shown that high levels of IL-17A in the blood can infiltrate the trigeminal nucleus and trigger central neuroinflammation, activating nociceptive pathways of migraine. This evidence concerns the gene IL17A and migraine disorder.